Serotonin Reuptake Inhibitors and Risk of Abnormal Bleeding

被引:39
|
作者
Andrade, Chittaranjan [1 ]
Sharma, Eesha [2 ]
机构
[1] Natl Inst Mental Hlth & Neurosci, Dept Psychopharmacol, Bangalore 560029, Karnataka, India
[2] King Georges Med Univ, Dept Psychiat, Lucknow 226003, Uttar Pradesh, India
关键词
Antidepressant; Serotonin reuptake inhibitor; Selective serotonin reuptake inhibitor; Bleeding; Postpartum hemorrhage; Intracranial hemorrhage; Nonsteroidal anti-inflammatory drugs; Antiplatelet drugs; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POPULATION-BASED COHORT; POSTPARTUM HEMORRHAGE; PREADOLESCENT GIRL; ANTIDEPRESSANTS; METAANALYSIS; STROKE; SERTRALINE; THERAPY; SURGERY;
D O I
10.1016/j.psc.2016.04.010
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Serotonin reuptake inhibitors (SRIs) increase the risk of abnormal bleeding by lowering platelet serotonin and hence the efficiency of platelet-driven hemostasis; by increasing gastric acidity and possibly gastric ulceration; and by other mechanisms. The upper gastrointestinal tract is the commonest site of SRI-related abnormal bleeding; bleeding at this location may be increased by concurrent nonsteroidal anti-inflammatory drug therapy and by treatment with antiplatelet or anticoagulant drugs. Bleeding at this location may be reduced by concurrent administration of acid-suppressing drugs.
引用
收藏
页码:413 / +
页数:15
相关论文
共 50 条
  • [41] Use of serotonin reuptake inhibitors is not associated with increased bleeding after CABG
    Heimisdottir, Alexandra A.
    Enger, Eric
    Morelli, Simon
    Johannesdottir, Hera
    Helgadottir, Solveig
    Sigurdsson, Engilbert
    Gudbjartsson, Tomas
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2020, 68 (11) : 1312 - 1318
  • [42] Selective Serotonin Reuptake Inhibitors and Gastrointestinal Bleeding: A Meta-Analysis
    Carvajal, A.
    Treceno, C.
    Sainz, M.
    Salado, I.
    Jimeno, N.
    Velasco, V.
    Martin Arias, L.
    DRUG SAFETY, 2011, 34 (10) : 944 - 945
  • [43] Use of serotonin reuptake inhibitors is not associated with increased bleeding after CABG
    Alexandra A. Heimisdottir
    Eric Enger
    Simon Morelli
    Hera Johannesdottir
    Solveig Helgadottir
    Engilbert Sigurðsson
    Tomas Gudbjartsson
    General Thoracic and Cardiovascular Surgery, 2020, 68 : 1312 - 1318
  • [44] Bleeding involved in selective serotonin reuptake inhibitors intake: a case report
    Berg, C
    Couturier, F
    Grass, F
    Aujoulat, O
    Guillard, D
    Stoeckel, C
    THERAPIE, 2001, 56 (01): : 65 - 67
  • [45] Serotonin reuptake inhibitors and post-gastrostomy bleeding: reevaluating the link
    Patel, Harish
    Gaduputi, Vinaya
    Sakam, Ailaja
    Kumar, Kishore
    Chime, Chukwunonso
    Balar, Bhavna
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2015, 11 : 1283 - 1289
  • [46] Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors
    Skop, BP
    Brown, TM
    PSYCHOSOMATICS, 1996, 37 (01) : 12 - 16
  • [47] Clinical impact of selective serotonin reuptake inhibitors therapy with bleeding risks
    Turner, M. S.
    May, D. B.
    Arthur, R. R.
    Xiong, G. L.
    JOURNAL OF INTERNAL MEDICINE, 2007, 261 (03) : 205 - 213
  • [48] Selective serotonin Reuptake inhibitors and risk of hemorrhagic stroke
    Kharofa, Jordan
    Sekar, Padmini
    Haverbusch, Mary
    Moomaw, Charles
    Flaherty, Matthew
    Kissela, Brett
    Broderick, Joseph
    Woo, Daniel
    STROKE, 2007, 38 (11) : 3049 - 3051
  • [49] Effect of selective serotonin reuptake inhibitors on the risk of fracture
    Richards, J. Brent
    Papaioannou, Alexandra
    Adachi, Jonathan D.
    Joseph, Lawrence
    Whitson, Heather E.
    Prior, Jerilynn C.
    Goltzman, David
    ARCHIVES OF INTERNAL MEDICINE, 2007, 167 (02) : 188 - 194
  • [50] Serotonin Reuptake Inhibitor Antidepressants and Abnormal Bleeding: A Review for Clinicians and a Reconsideration of Mechanisms
    Andrade, Chittaranjan
    Sandarsh, Surya
    Chethan, Kumar B.
    Nagesh, Koregala S.
    JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (12) : 1565 - 1575